Regeneron beats quarterly revenue estimates
Feb 2 (Reuters) - Drug maker Regeneron beat fourth-quarter revenue estimates on Friday.
Total revenue for the quarter was $3.43 billion, beating analysts' estimates of $3.29 billion, according to LSEG data. (Reporting by Sriparna Roy in Bengaluru)